| scholarly article | Q13442814 |
| P2093 | author name string | Lin Yuan | |
| Xiaoyan Zhou | |||
| Ping Wei | |||
| Yayun Chi | |||
| Xiaochen Chen | |||
| Weiqi Sheng | |||
| Daren Shi | |||
| Weixiang Chen | |||
| P2860 | cites work | Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis | Q22122362 |
| Global cancer statistics | Q22241238 | ||
| hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6 | Q24323176 | ||
| Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer | Q24614511 | ||
| Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability | Q24618618 | ||
| Microsatellite instability in colorectal cancer | Q24627393 | ||
| Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer | Q28249924 | ||
| PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | Q28262647 | ||
| A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 | ||
| Systematic review of microsatellite instability and colorectal cancer prognosis | Q28303189 | ||
| Stepwise deletions of polyA sequences in mismatch repair-deficient colorectal cancers | Q28507252 | ||
| Microsatellite instability in cancer of the proximal colon | Q29620692 | ||
| Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer | Q30588580 | ||
| The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside | Q33762979 | ||
| Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history | Q33910331 | ||
| Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study | Q34102606 | ||
| Defective mismatch-repair colorectal cancer: clinicopathologic characteristics and usefulness of immunohistochemical analysis for diagnosis. | Q34550752 | ||
| Microsatellite instability and the clinicopathological features of sporadic colorectal cancer | Q35363901 | ||
| Histopathological identification of colon cancer with microsatellite instability | Q35746344 | ||
| Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis | Q35747184 | ||
| Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer | Q35988113 | ||
| Extensive molecular screening for hereditary non-polyposis colorectal cancer | Q36641429 | ||
| Classification of colorectal cancer based on correlation of clinical, morphological and molecular features | Q36699559 | ||
| Feasibility of screening for Lynch syndrome among patients with colorectal cancer | Q37103121 | ||
| Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. | Q37157691 | ||
| CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer | Q37185561 | ||
| Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiency | Q37221983 | ||
| Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant | Q37360286 | ||
| A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas | Q37866075 | ||
| Complementation of an hMSH2 defect in human colorectal carcinoma cells by human chromosome 2 transfer | Q38307828 | ||
| Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. | Q38360916 | ||
| Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer | Q38449001 | ||
| Trends in cancer mortality in China: an update | Q40029893 | ||
| Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. | Q41086058 | ||
| Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation | Q41448577 | ||
| Molecular biology of colorectal cancer | Q41686589 | ||
| Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair | Q42134566 | ||
| Morphology of sporadic colorectal cancer with DNA replication errors | Q43087650 | ||
| Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival | Q43778696 | ||
| Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer | Q44605110 | ||
| The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study | Q44628695 | ||
| Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer | Q47209748 | ||
| Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. | Q53353136 | ||
| Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. | Q53439660 | ||
| Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. | Q54596227 | ||
| MSI-low, a real phenomenon which varies in frequency among cancer types. | Q54745600 | ||
| Colorectal cancer | Q57191694 | ||
| Low-level microsatellite instability in most colorectal carcinomas | Q57240042 | ||
| Use of Molecular Tumor Characteristics to Prioritize Mismatch Repair Gene Testing in Early-Onset Colorectal Cancer | Q57265834 | ||
| Prognosis of colorectal cancer varies in different high-risk conditions | Q58264884 | ||
| Hereditary colorectal cancer | Q73088287 | ||
| Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability | Q73322611 | ||
| Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma | Q74046178 | ||
| Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families | Q74309292 | ||
| Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors | Q77639637 | ||
| Histopathology and Mismatch Repair Status of 458 Consecutive Colorectal Carcinomas | Q79203530 | ||
| Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer | Q79203534 | ||
| Clinicopathologic factors identify sporadic mismatch repair-defective colon cancers | Q80522940 | ||
| Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer | Q80557773 | ||
| Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms | Q81186123 | ||
| Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining | Q81333266 | ||
| Molecular Genetics of Colorectal Cancer | Q82521439 | ||
| Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel | Q84452748 | ||
| Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma | Q84570529 | ||
| P433 | issue | 11 | |
| P921 | main subject | microsatellite | Q265193 |
| immunohistochemistry | Q899285 | ||
| DNA mismatch repair | Q2984243 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 20988-21000 | |
| P577 | publication date | 2015-11-15 | |
| P1433 | published in | International Journal of Clinical and Experimental Medicine | Q6051338 |
| P1476 | title | Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency | |
| P478 | volume | 8 |
| Q43056671 | Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas |
| Q52659178 | Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer. |
| Q48775299 | Clinical Impact of Mismatch Repair Protein Testing on Outcome of Early Staged Colorectal Carcinomas |
| Q37631539 | Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients. |
| Q92646254 | Clinicopathological features and prognostic value of mismatch repair protein deficiency in gastric cancer |
| Q58220331 | DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma |
| Q40544225 | Distinct expression profile of key molecules in crawling-type early gastric carcinoma |
| Q89849938 | Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions |
| Q64072331 | Exploiting DNA repair defects in colorectal cancer |
| Q92839477 | Immunohistochemical Expression of MMR Proteins with Clinicopathological Correlation in Colorectal Cancer in Egypt |
| Q47614611 | Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review |
| Q90749821 | Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer |
| Q49787899 | Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer |
| Q37658749 | Mismatch Repair Proteins and Microsatellite Instability in Colorectal Carcinoma (MLH1, MSH2, MSH6 and PMS2): Histopathological and Immunohistochemical Study |
| Q37687784 | Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm |
| Q28080176 | Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer |
| Q64967557 | The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors. |
Search more.